Extensive vascular malformations involving a limb and major named veins may require repeated treatment over many years. Their abnormal venous anatomy may remain clinically important even when local symptoms are controlled, particularly when subsequent interventions are planned. We report the long-term course of a 26-year-old man with a congenital vascular malformation involving the pelvis and right lower extremity, diagnosed at 13 years of age and historically described as an arteriovenous malformation. Historical CT angiography reports described arteriovenous components together with extensive venous abnormalities, including aneurysmal dilatation of the right popliteal and external iliac veins. Staged surgery during adolescence was followed by an approximately 13-year interval without further invasive treatment, during which the patient initially remained clinically stable before gradually developing recurrent symptoms. At 26 years of age, progressive symptoms prompted combined endovenous laser treatment, electrocoagulation, and sclerotherapy. On postoperative day 7, the patient developed occlusive right popliteal venous thrombosis and acute bilateral pulmonary embolism requiring systemic thrombolysis followed by anticoagulation. The patient stabilized after treatment. At approximately 3-month cardiology follow-up, he was asymptomatic, with preserved cardiac function and good exercise tolerance. Longer-term symptom control was maintained with class III compression therapy, therapeutic exercise, and regular physical activity, with improvement in pain and lower-extremity edema. This case illustrates that major venous abnormalities may remain clinically relevant throughout the long-term course of a complex vascular malformation. In patients undergoing further intervention, lesion-specific venous anatomy and pre-existing thrombotic changes within malformed venous spaces should be considered alongside conventional peri-procedural thromboembolic risk factors. Long-term management should remain individualized and focused on symptoms, function, and surveillance of major vascular abnormalities.
INTRODUCTION Depression is a common and serious mood disorder mainly manifested by sadness, anhedonia, lack of hope and interest in activities once enjoyed. According to WHO depression is a leading cause of disability and inability to work worldwide. Chronic disease is every condition lasting more than 1 year and requiring medical attention. The aim of this article is to show challenges of depression and chronic diseases coexistence. DISCUSSION Depression might be a factor causing difficulties in diagnosing chronic diseases as patients are less likely to cooperate. On the other it might lead to worse compliance and higher risk of chronic diseases’ development. Studies show depression coexisting with chronic illnesses is a valid problem for public health and aggravates the course and effects of treatment of those conditions. Treating an underlying disease is as important as treating depression itself as it might lead to reduction in symptoms of depression. Moreover doctors should choose drugs having regard to depression as well as lingering conditions. SUMMARY Depression still seems to be diminished and ignored in patients with chronic illnesses even though it is proved to have a destructive influence on the health of patients. It is of high importance to raise an awareness of doctors on that subject and its scale. There are plenty of treatment methods for depression in case of chronic diseases co-occurence which gives hope for improving a quality of life of patients and achieving better effects of therapy of an underlying disease.
Diabetes Mellitus is one of the most common civilization diseases.The incidence of this disease has been increasing over the last few decades. Research is still being conducted to show the relationship between diabetes and other diseases. Based on these studies, it can be concluded that it also plays a role in the development of cancer. In this review, we focus on analyzing studies on the relationship between type 2 diabetes and breast cancer. We show the influence of diabetes components on the pathomechanism of breast cancer development. We focus on hyperinsulinemia, inflammatory processes, oxidative stress, and obesity, which often accompany type 2 diabetes. Based on the analyzed studies, it can be concluded that type 2 diabetes is a significant factor contributing to cancerous processes associated with breast cancer. In this review, we used articles available in the PubMed database.
Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy. It is characterized by hyperglycemia resulting from impaired tissue sensitivity to insulin secreted by pancreatic beta cells. This is due to the action of hormones secreted by the placenta that oppose insulin. The incidence of gestational diabetes continues to increase, posing many potential risks to both mother and fetus. Importantly, these complications also have a long-term dimension. It has been proven that in adulthood, in children born from pregnancies complicated by gestational diabetes, the risk of developing obesity, type II diabetes and cardiovascular diseases increases. Their mothers are also at a similar risk. The main goal of treatment of gestational diabetes is to achieve normoglycaemia. Appropriate dietary management is recommended, and if this is not sufficient, insulin therapy should be initiated.
Introduction and objective: Epinephrine is the most important and primary drug that resuscitation team use to reverse cardiac arrest. The provision of epinephrine is currently suggested by both the American Heart Association and the European Resuscitation Council. It is vital to improving the return of spontaneous circulation (ROSC), however the evidence for the use of adrenaline in resuscitation is inconclusive. Materials and methods: The literature was reviewed in the Pubmed database, in the Via Medica Journals database, and in the guidelines of the Polish Society of Anesthesiology, European Resuscitation Council and the American Heart Association with the use of keywords. State of knowledge: There is a clear evidence of an association between epinephrine and increased return of spontaneous circulation (ROSC). Its action is based on stimulation of alpha- and beta-adrenergic receptors. Epinephrine have a role in resuscitation, during CPR it increases the probability of restoring cardiac activity with pulses, which is intermediate step toward long-term survival. However, there are conflicting results regarding long-term survival and functional recovery, particularly neurological outcome. Conclusions: Research shows that epinephrine administration in patients with cardiac arrest increases the chance of restoring spontaneous circulation and patient survival to hospital admission and discharge. However, there are arguments questioning the validity of using epinephrine in resuscitation. Publications show that the compound contributes to post-resuscitation syndrome, which reduces a patient's chance of long-term survival. There are a number of conflicting studies that vary widely in the results presented. The current evidence is insufficient to either confirm or exclude the efficacy of epinephrine, which is why it is still recommended in the latest resuscitation guidelines by the European Resuscitation Council (ERC 2021) and the American Heart Association (AHA 2020).